Abstract:Aerobic vaginitis (AV) is a vaginal infectious condition which is often confused with bacterial vaginosis (BV) or with the intermediate microflora as diagnosed by Nugent's method to detect BV on Gram-stained specimens. However, although both conditions reflect a state of lactobacillary disruption in the vagina, leading to an increase in pH, BV and AV differ profoundly. While BV is a noninflammatory condition composed of a multiplex array of different anaerobic bacteria in high quantities, AV is rather sparely populated by one or two enteric commensal flora bacteria, like Streptococcus agalactiae, Staphylocuccus aureus, or Escherichia coli. AV is typically marked by either an increased inflammatory response or by prominent signs of epithelial atrophy or both. The latter condition, if severe, is also called desquamative inflammatory vaginitis. As AV is per exclusionem diagnosed by wet mount microscopy, it is a mistake to treat just vaginal culture results. Vaginal cultures only serve as follow-up data in clinical research projects and are at most used in clinical practice to confirm the diagnosis or exclude Candida infection. AV requires treatment based on microscopy findings and a combined local treatment with any of the following which may yield the best results: antibiotic (infectious component), steroids (inflammatory component), and/or estrogen (atrophy component). In cases with Candida present on microscopy or culture, antifungals must be tried first in order to see if other treatment is still needed. Vaginal rinsing with povidone iodine can provide rapid relief of symptoms but does not provide long-term reduction of bacterial loads. Local antibiotics most suitable are preferably non-absorbed and broad spectrum, especially those covering enteric gram-positive and gram-negative aerobes, like kanamycin. To achieve rapid and short-term improvement of severe symptoms, oral therapy with amoxyclav or moxifloxacin can be used, especially in deep dermal vulvitis and colpitis infections with group B streptococci or (methicillin resistant) Staphylococcus aureus. Since the latter colonizations are frequent, but seldom inflammatory infections, we in general discourage the use of oral antibiotics in women with AV. In cases with a severe atrophy component (more than 10 % of epithelial cells are of the parabasal type), local estrogens can be used; and in postmenopausal or breast cancer patients with a contraindication for estrogens, even a combination of probiotics with an ultra-low dose of local estriol may be considered.

Management of Persistent Vaginitis

Vaginitis: Diagnosis and Management

Recurrent Infectious Vaginitis: A Practical Approach for the Primary Care Clinician

Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion

Mixed Vaginitis Due to Bacterial Vaginosis and Candidiasis

Selecting anti-microbial treatment of aerobic vaginitis

Probiotics in the Management of Vulvovaginal Candidosis

Evaluation and Management of Vaginitis

Recurrent vulvovaginal candidiasis with Candida glabrata - a management conundrum

Beyond fluconazole: A review of vulvovaginal candidiasis diagnosis and treatment

Management of postmenopausal vulvovaginal atrophy: recommendations of the International Society for the Study of Vulvovaginal Disease

Fluconazole-Resistant Vulvovaginal Candidosis: An Update on Current Management

Recurrent genital 45 cases of vaginal Candida disease clinical treatment experience

Increasing rate of non- Candida albicans yeasts and fluconazole resistance in yeast isolates from women with recurrent vulvovaginal candidiasis in Leeds, United Kingdom

Biofilm in Bacterial Vaginosis: A Legitimate Therapeutic Challenge?

Pharmacotherapy for the treatment of vaginal atrophy

Lived experience of medical management in recurrent vulvovaginal candidiasis: a qualitative study of an uncertain journey

Investigate the Pathogen Flora and the Treatment of Recurrent Vulvovaginal Candidiasis

Vulvovaginal Candidiasis: Epidemiology and Risk Factors, Pathogenesis, Resistance, and New Therapeutic Options

Vulvovaginal Candidiasis: A Current Understanding and Burning Questions

Vaginal pH Value for Clinical Diagnosis and Treatment of Common Vaginitis